| 生物活性 | Arabinoxylan Medium viscosity is an orally active Dectin-1 (CLEC7A) splice variant modulator, glucose absorption inhibitor, and chyme viscosity enhancer that inhibits particulate β-glucan-induced Dectin-1A activation and mildly inhibits Dectin-1B activation, decreases IL-10 and TNF-α production while increasing IL-4 and IL-23 production in human dendritic cells stimulated with particulate β-glucan, supports antifungal immune responses without activating TLR2, TLR4, or TLR5 and without inducing cytokine production when used to stimulate human dendritic cells alone; moreover, it increases small intestinal chyme viscosity, is degraded in the large intestine to produce short-chain fatty acids, reduces glucose absorption and insulin response, and improves glucose homeostasis, supports microbial fermentation, beneficial microbiota growth, inhibition of bile acid reabsorption, and delayed starch digestion in the gastrointestinal tract, and can be used in research related to type 2 diabetes, impaired glucose tolerance, and metabolic syndrome. | ||||||||||||||||
| IC50 & Target |
|
||||||||||||||||
| 体外研究 (In Vitro) |
Arabinoxylan 溶液的粘度随浓度升高显著增大,表现出剪切稀化特性;低粘度下以粘性行为为主,高粘度下分子链发生超缠结 (hyperentanglement),粘弹性向弹性转变,且溶液遵循 Cox-Merz 规则,无复杂长程结构。 |
||||||||||||||||
| 体内研究 (In Vivo) |
Arabinoxylan Medium viscosity (占干物质的 7.8%;口服;单剂量) 可降低门静脉插管猪在 60 分钟时的门静脉葡萄糖净吸收量,并降低其在 30 分钟时的胰岛素分泌水平。
|
||||||||||||||||
| 性状 | 固体 | ||||||||||||||||
| 颜色 | White to off-white |
| CAS No. | 9040-27-1 |
| 溶解度信息 | H2O: 16 mg/mL, Sonication is recommended. |
||||||
| 储存方式 | Store at room temperature 3 years
|
||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。